Free Trial
OTCMKTS:PMCBD

PharmaCyte Biotech (PMCBD) Stock Price, News & Analysis

PharmaCyte Biotech logo
$1.01 -0.04 (-3.79%)
As of 05/27/2025

About PharmaCyte Biotech Stock (OTCMKTS:PMCBD)

Key Stats

Today's Range
$1.01
$1.12
50-Day Range
$1.01
$1.58
52-Week Range
$5.56
$55.50
Volume
27,598 shs
Average Volume
8,831 shs
Market Capitalization
$1.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.

Receive PMCBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter.

PMCBD Stock News Headlines

PharmaCyte Biotech (PMCB) Earnings Dates & Reports
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
PharmaCyte Biotech Inc (PMCB)
Exploring beauty’s biotech frontier
PMCB PharmaCyte Biotech, Inc.
Baltimore Biotech News
See More Headlines

PMCBD Stock Analysis - Frequently Asked Questions

PharmaCyte Biotech's stock was trading at $1.55 at the beginning of the year. Since then, PMCBD stock has decreased by 34.8% and is now trading at $1.0102.
View the best growth stocks for 2025 here
.

Shares of PMCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:PMCBD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.83 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.69 million
Optionable
Not Optionable
Beta
0.27
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:PMCBD) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners